Hospitals to get drug for serious Covid-19 patients

Published July 17, 2020
Officials say Remdesivir will not be available over the counter to prevent hoarding. — AP/File
Officials say Remdesivir will not be available over the counter to prevent hoarding. — AP/File

PESHAWAR: The government has decided to provide Remdesivir injection for the treatment of serious Covid-19 patients initially to the hospitals only as Ferozsons Laboratories is ready to start supply of the drug from July 28 to the market, according to officials.

Officials at Drug Regulatory Authority of Pakistan (DRAP) told Dawn that Remdesivir injection for Covid-19, manufactured by BF Biosciences Lahore under agreement with Gilead sciences USA, would be available in the end of current month with brand name Remedia both in lyuphized powder for infusion and in liquid form.

“We are going to supply 25,000 injections to the market that are presently undergoing sterility tests after which these will be tested at Central Drug Testing Laboratory, Karachi before making them available for patients,” they said.

On June 8, DRAP allowed 12 firms to manufacture or import Remdesivir in liquid and powder form for the treatment of Covid-19 patients in the country. Another firm has imported the drug from Bangladesh but Ferozsons is manufacturing the injections in Lahore in collaboration with Gilead Sciences USA, which has originally developed it.

“The government and the companies have signed agreements that the drug would not made available over-the-counter but will be supplied to the hospitals directly where Covid-19 patients are treated,” said the officials. The measure are meant to

Officials say Remdesivir will not be available over the counter to prevent hoarding

put brakes on black-marketing of the injection given the experience of the past few months, which saw skyrocketing prices of some anti-inflammatory drugs used for the treatment of Covid-19 patients.

Officials said that trial and commercials batches had satisfactory results and were ready for use but as precaution they were waiting for sterility tests. The price of per injection will be Rs10,800 or Rs12,800 and the patients would require six injections.

They will need two injections on the first day, followed by one injection daily for four days. In more severe cases 11 injections will be needed, depending on the advice of physicians.

The approval regarding powder came in emergency for the companies that had lyophilisation facility and could store the product at below 24 degree centigrade, the officials said.

They added that for liquid injection, the factories having cool chain facilities of 2-degree centigrade to 8-degree centigrade were allowed.

Officials said that Remdesivir was available worldwide in 20 ml liquid injection vials as well as in freeze-dried form, to be reconstituted for injection after mixing of distilled water. They said both forms were allowed by DRAP.

They said that hospitals would send demand to the company that would supply the drug on the basis of needs. They added that the manufacturer got raw material for 100,000 injections and it could be imported once situation regarding demand in the country became clear.

There has been rising demand for the medicine owing to the severity of the pandemic as each and every country requires the injections approved by the US Food and Drug Administration as well as European countries.

“In view of the shortages of anti-Covid-19 drugs, the government has bound all the manufacturers to restrict sale to the hospitals only to discourage hoarding and sale in open market,” said the officials.

They said that sale over-the-counter could not be allowed because the drug would be required by the serious patients, who remained on ventilators. Serious patients on ventilator could only be in hospitals, therefore, it was decided to sell the stuff to hospitals only, they added.

Published in Dawn, July 17th, 2020

Opinion

Editorial

Judiciary’s SOS
Updated 28 Mar, 2024

Judiciary’s SOS

The ball is now in CJP Isa’s court, and he will feel pressure to take action.
Data protection
28 Mar, 2024

Data protection

WHAT do we want? Data protection laws. When do we want them? Immediately. Without delay, if we are to prevent ...
Selling humans
28 Mar, 2024

Selling humans

HUMAN traders feed off economic distress; they peddle promises of a better life to the impoverished who, mired in...
New terror wave
Updated 27 Mar, 2024

New terror wave

The time has come for decisive government action against militancy.
Development costs
27 Mar, 2024

Development costs

A HEFTY escalation of 30pc in the cost of ongoing federal development schemes is one of the many decisions where the...
Aitchison controversy
Updated 27 Mar, 2024

Aitchison controversy

It is hoped that higher authorities realise that politics and nepotism have no place in schools.